Literature DB >> 22392834

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

Reina Armamento-Villareal1, Corinn Sadler, Nicola Napoli, Krupa Shah, Suresh Chode, David R Sinacore, Clifford Qualls, Dennis T Villareal.   

Abstract

We reported that weight loss induces bone loss which is prevented by exercise training; however, the mechanism for this observation remains unclear. Sclerostin, an inhibitor of bone formation, has been found to increase in states of unloading and may mediate the changes in bone metabolism associated with weight loss and exercise. The objective of the study was to determine the effect of lifestyle intervention in obese older adults on sclerostin levels, and on hip geometry parameters. A total of 107 obese (body mass index [BMI] ≥ 30 kg/m(2)) older (≥65 years) adults were randomly assigned to control, diet, exercise, and combined diet-exercise for 1 year. Sclerostin levels were measured by ELISA at baseline, 6 months, and 12 months, while hip geometry parameters were obtained from bone mineral density (BMD) images done by dual-energy X-ray absorptiometry using hip structure analysis at baseline and 12 months. Both the diet and diet-exercise groups had significant decreases in body weight (-9.6% and -9.4%, respectively), whereas weight was stable in the exercise and control groups. Sclerostin levels increased significantly and progressively in the diet group (6.6% ± 1.7% and 10.5% ± 1.9% at 6 and 12 months, respectively, all p < 0.05), whereas they were unchanged in the other groups; in particular, they were stable in the diet-exercise group (0.7% ± 1.6% and 0.4% ± 1.7% at 6 and 12 months, respectively, all p = 0.05). Hip geometry parameters showed significant decreases in cross-sectional area, cortical thickness, and BMD; and increases in buckling ratio at the narrow neck, intertrochanter, and femoral shaft. These negative changes on bone geometry were not observed in the diet-exercise group. Significant correlations between changes in sclerostin and changes in certain hip geometry parameters were also observed (p < 0.05). In conclusion, the increase in sclerostin levels with weight loss that was prevented by exercise may partly mediate the negative effects of weight loss on bone metabolism and the osteoprotective effect of exercise training.
Copyright © 2012 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392834      PMCID: PMC3361603          DOI: 10.1002/jbmr.1560

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  37 in total

Review 1.  Relationships among body mass, its components, and bone.

Authors:  I R Reid
Journal:  Bone       Date:  2002-11       Impact factor: 4.398

2.  Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women.

Authors:  Mariana Cifuentes; Claudia S Riedt; Robert E Brolin; M Paul Field; Robert M Sherrell; Sue A Shapses
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

3.  In vivo short-term precision of hip structure analysis variables in comparison with bone mineral density using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials.

Authors:  Benjamin C C Khoo; Thomas J Beck; Qi-Hong Qiao; Pallav Parakh; Lisa Semanick; Richard L Prince; Kevin P Singer; Roger I Price
Journal:  Bone       Date:  2005-07       Impact factor: 4.398

4.  Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women.

Authors:  Y E Chung; S H Lee; S-Y Lee; S-Y Kim; H-H Kim; F S Mirza; S-K Lee; J A Lorenzo; G S Kim; J-M Koh
Journal:  Osteoporos Int       Date:  2011-06-10       Impact factor: 4.507

5.  SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.

Authors:  Mikhail Semënov; Keiko Tamai; Xi He
Journal:  J Biol Chem       Date:  2005-05-20       Impact factor: 5.157

6.  Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data.

Authors:  T J Beck; A C Looker; C B Ruff; H Sievanen; H W Wahner
Journal:  J Bone Miner Res       Date:  2000-12       Impact factor: 6.741

7.  Bone loss accompanying voluntary weight loss in obese humans.

Authors:  L B Jensen; F Quaade; O H Sørensen
Journal:  J Bone Miner Res       Date:  1994-04       Impact factor: 6.741

8.  Femoral bone structural geometry adapts to mechanical loading and is influenced by sex steroids: the Penn State Young Women's Health Study.

Authors:  Moira A Petit; Thomas J Beck; Hung-Mo Lin; Christy Bentley; Richard S Legro; Tom Lloyd
Journal:  Bone       Date:  2004-09       Impact factor: 4.398

9.  Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.

Authors:  May Kung Sutherland; James C Geoghegan; Changpu Yu; Eileen Turcott; John E Skonier; David G Winkler; John A Latham
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

10.  Bone loss accompanying diet-induced or exercise-induced weight loss: a randomised controlled study.

Authors:  J E Pritchard; C A Nowson; J D Wark
Journal:  Int J Obes Relat Metab Disord       Date:  1996-06
View more
  62 in total

Review 1.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

Review 2.  Bone Health following Bariatric Surgery: Implications for Management Strategies to Attenuate Bone Loss.

Authors:  Tair Ben-Porat; Ram Elazary; Shiri Sherf-Dagan; Ariela Goldenshluger; Ronit Brodie; Yoav Mintz; Ram Weiss
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

Review 3.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

4.  Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.

Authors:  Yu-Heng Vivian Ma; Ann V Schwartz; Sigurdur Sigurdsson; Trisha F Hue; Thomas F Lang; Tamara B Harris; Clifford J Rosen; Eric Vittinghoff; Gudny Eiriksdottir; Alda M Hauksdottir; Kristin Siggeirsdottir; Gunnar Sigurdsson; Diana Oskarsdottir; Nicola Napoli; Lisa Palermo; Vilmundur Gudnason; Xiaojuan Li
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

5.  Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists.

Authors:  Dag Hofsø; Jens Bollerslev; Rune Sandbu; Anders Jørgensen; Kristin Godang; Jøran Hjelmesæth; Thor Ueland
Journal:  Endocrine       Date:  2016-03-08       Impact factor: 3.633

6.  Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.

Authors:  Maria Fernanda G Biagioni; Adriana L Mendes; Célia Regina Nogueira; Celso V Leite; Loraine Gollino; Gláucia Mfs Mazeto
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

7.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

Review 8.  Effects of myokines on bone.

Authors:  Hiroshi Kaji
Journal:  Bonekey Rep       Date:  2016-07-20

Review 9.  Hormonal and systemic regulation of sclerostin.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Bone       Date:  2016-12-10       Impact factor: 4.398

Review 10.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.